Related references
Note: Only part of the references are listed.Screen and confirmation of PEG-epoetin beta in equine plasma
Y. Chang et al.
DRUG TESTING AND ANALYSIS (2011)
A strategy for liquid chromatography/tandem mass spectrometry based quantitation of pegylated protein drugs in plasma using plasma protein precipitation with water-miscible organic solvents and subsequent trypsin digestion to generate surrogate peptides for detection
Steven T. Wu et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2011)
Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry
Nola H. Yu et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2010)
Immunoaffinity Purification Using Anti-PEG Antibody Followed by Two-Dimensional Liquid Chromatography/Tandem Mass Spectrometry for the Quantification of a PEGylated Therapeutic Peptide in Human Plasma
Yang Xu et al.
ANALYTICAL CHEMISTRY (2010)
Elucidation of PEGylation Site with a Combined Approach of In-Source Fragmentation and CID MS/MS
Xiaojun Lu et al.
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2010)
Characterization of Poly(ethylene glycol) and PEGylated Products by LC/MS with Postcolumn Addition of Amines
Lihua Huang et al.
ANALYTICAL CHEMISTRY (2009)
Hematopoietic growth factor mimetics: From concept to clinic
Michelle Perugini et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2009)
SARCOSYL-PAGE: a new method for the detection of MIRCERA- and EPO-doping in blood
Christian Reichel et al.
DRUG TESTING AND ANALYSIS (2009)
Emerging drugs: mechanism of action, mass spectrometry and doping control analysis
Mario Thevis et al.
JOURNAL OF MASS SPECTROMETRY (2009)
A high-throughput test to detect CERA doping in blood
Severine Lamon et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia.
Iain C. Macdougall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Hematide™ for the treatment of chronic kidney disease-related anemia
Francesco Locatelli et al.
EXPERT REVIEW OF HEMATOLOGY (2009)
The impact of PEGylation on biological therapies
Francesco M. Veronese et al.
BIODRUGS (2008)
Erythropoiesis-stimulating agents and other methods to enhance oxygen transport
S. Elliott
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Preclinical safety and pharmacology of hematide (TM), a peptidic erythropoiesis stimulating agent (ESA), in rats and monkeys
Kathryn W. Woodburn et al.
DRUG AND CHEMICAL TOXICOLOGY (2008)
Enrichment of low molecular weight serum proteins using acetonitrile precipitation for mass spectrometry based proteomic analysis
Richard Kay et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2008)
Resolving oligomers from fully grown polymers with IMS-MS
Sarah Trimpin et al.
ANALYTICAL CHEMISTRY (2007)
Native PAGE eliminates the problem of PEG-SDS interaction in SDS-PAGE and rovides an alternative to HPLC in 2 characterization of protein PEGylation
Chunyang Y. Zheng et al.
ELECTROPHORESIS (2007)
Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers
Richard B. Stead et al.
BLOOD (2006)
PEGylation, successful approach to drug delivery
FM Veronese et al.
DRUG DISCOVERY TODAY (2005)
Ion suppression in mass spectrometry
TM Annesley
CLINICAL CHEMISTRY (2003)
Share Paper
